Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripherally and Centrally Acting Muscle Relaxants: A Comparison01:09

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

4.6K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
4.6K
The Central Dogma01:25

The Central Dogma

139.9K
Overview
139.9K
The Central Dogma01:20

The Central Dogma

33.9K
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
33.9K
Measures of Central Tendency02:16

Measures of Central Tendency

21.3K
The "center" of a data set is also a way of describing location. The two most widely used measures of the "center" of the data are the mean (average) and the median. The words "mean" and "average" are often used interchangeably. The substitution of one word for the other is common practice. The technical term is "arithmetic mean" and "average" is technically a center location. However, in practice among non-statisticians,...
21.3K
Inhaled Medications01:23

Inhaled Medications

806
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
806
Hybridoma Technology01:31

Hybridoma Technology

17.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR).

BMJ (Clinical research ed.)·2026
Same author

Factors Associated with Hematuria Resolution and Hematuria Admissions After Hyperbaric Oxygen Therapy for Chronic Radiation Cystitis.

Urology practice·2026
Same author

Relationships between Toenail, Urinary, and Drinking-water Fluoride Concentrations in a Pregnancy Cohort using Private Water Systems in the United States.

Biological trace element research·2026
Same author

Community Optometrist-Led Monitoring of Quiescent Neovascular Age-Related Macular Degeneration: The FENETRE Randomized Clinical Trial.

JAMA network open·2026
Same author

The costs and benefits of an early access scheme for oncology medicines in Ireland.

BMC health services research·2026
Same author

Time-Varying Exposure to Element Mixtures and Children's Cognition at 5 Years of Age: Findings from the New Hampshire Birth Cohort Study.

Environmental health perspectives·2026

Related Experiment Video

Updated: Feb 6, 2026

The Supraclavicular Fossa Ultrasound View for Central Venous Catheter Placement and Catheter Change Over Guidewire
07:47

The Supraclavicular Fossa Ultrasound View for Central Venous Catheter Placement and Catheter Change Over Guidewire

Published on: December 23, 2014

20.2K

SecurAcath for Securing Peripherally Inserted Central Catheters: A NICE Medical Technology Guidance.

Tom Macmillan1, Mark Pennington2, Jennifer A Summers3

  • 1King's Technology Evaluation Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, 5th Floor, Becket House, 1 Lambeth Palace Road, London, SE1 7EU, UK. thomas.macmillan@kcl.ac.uk.

Applied Health Economics and Health Policy
|August 21, 2018
PubMed
Summary

SecurAcath offers a securement solution for central venous catheters. While StatLock may be more cost-effective for short-term use, SecurAcath proves more economical for medium- and long-term catheter indwell times.

More Related Videos

Early Metamorphic Insertion Technology for Insect Flight Behavior Monitoring
19:14

Early Metamorphic Insertion Technology for Insect Flight Behavior Monitoring

Published on: July 12, 2014

15.1K
Author Spotlight: Hickman Catheter Use for Long-Term Vascular Access in a Preclinical Swine Model
08:51

Author Spotlight: Hickman Catheter Use for Long-Term Vascular Access in a Preclinical Swine Model

Published on: March 31, 2023

5.5K

Related Experiment Videos

Last Updated: Feb 6, 2026

The Supraclavicular Fossa Ultrasound View for Central Venous Catheter Placement and Catheter Change Over Guidewire
07:47

The Supraclavicular Fossa Ultrasound View for Central Venous Catheter Placement and Catheter Change Over Guidewire

Published on: December 23, 2014

20.2K
Early Metamorphic Insertion Technology for Insect Flight Behavior Monitoring
19:14

Early Metamorphic Insertion Technology for Insect Flight Behavior Monitoring

Published on: July 12, 2014

15.1K
Author Spotlight: Hickman Catheter Use for Long-Term Vascular Access in a Preclinical Swine Model
08:51

Author Spotlight: Hickman Catheter Use for Long-Term Vascular Access in a Preclinical Swine Model

Published on: March 31, 2023

5.5K

Area of Science:

  • Medical Devices
  • Health Technology Assessment
  • Clinical Engineering

Background:

  • Central venous catheters (CVCs) are crucial for patient therapy and monitoring.
  • Effective securement of CVCs is essential to prevent dislodgement.
  • SecurAcath is a novel device for CVC securement.

Purpose of the Study:

  • To evaluate the clinical and economic evidence for the SecurAcath device.
  • To compare SecurAcath against alternative catheter securement methods.
  • To inform National Institute for Health and Care Excellence (NICE) guidance on CVC securement.

Main Methods:

  • Systematic review and meta-analysis of existing evidence.
  • Independent critique of manufacturer-submitted clinical and economic data.
  • Development and revision of a cost-effectiveness economic model.

Main Results:

  • Limited comparative evidence initially identified; one unpublished RCT showed potential non-inferiority to StatLock.
  • Revised economic model indicated StatLock is more cost-effective for ≤5-day indwell times.
  • SecurAcath demonstrated greater cost-effectiveness for medium- and long-term catheter use.

Conclusions:

  • SecurAcath shows potential non-inferiority to StatLock for CVC securement.
  • Cost-effectiveness varies by catheter indwell duration.
  • NICE recommended SecurAcath adoption for specific CVC applications in the NHS.